Extensive global participation has resulted in a large, standardised collection of comprehensive clinical data from hundreds of sites across dozens of countries.
Data are analysed regularly and reported publicly to inform patient care and public health response. This report, our 17th report, is a part of a series published over the past 2 years. Data have been entered for , individuals from partner institutions and networks across 60 countries. A global federation of clinical research networks, providing a proficient, coordinated, and agile research response to outbreak-prone infectious diseases.
This report describes the clinical presentation, treatment and outcome of a cohort of over , patients with COVID hospitalised between January and January in 60 countries.
After over million cases and over 6 million deaths, COVID is clearly showing us how pandemics disrupt populations by stretching healthcare systems, and shaking economies. Although clinicians and well-equipped surveillance systems can adapt to health emergencies by implementing new treatments and information systems, clinical research lacks this agility.
Novel diseases are, by definition, new; the scientific method is not. By developing consensus on a road map for clinical research methods before a pandemic, we are able to minimise further time defining study types, data collection tools, and potential outputs for evidence summarisation once the pathogen emerges.
